VERSITI BLOOD HEALTH, INC.

VERSITI WISCONSIN, INC. specializes in the manufacturing, collection, processing, and distribution of blood and biological products for federal healthcare systems, with deep expertise in transfusion medicine and laboratory services. The company operates as a full-service blood bank and biological products manufacturer, delivering safe, compliant, and traceable blood components, plasma derivatives, and related therapeutic agents under stringent regulatory standards. Their technical capabilities encompass aseptic processing, cryopreservation, pathogen reduction technologies, and quality control systems aligned with AABB, FDA, and CDC guidelines. They also support specialized patient testing and transfusion medicine research, demonstrating proficiency in immunohematology, serological screening, and donor management systems. The contractor maintains a strong, sustained relationship with the Department of Veterans Affairs, consistently providing blood and blood products to support veteran healthcare networks, particularly within VHA VISN 12. They also deliver critical transfusion medicine services to the Department of Health and Human Services, including specialized testing and research initiatives under programs such as REDS-IV-P, underscoring their role in national blood supply resilience and biomedical innovation. Their primary industry focus is biological product manufacturing (NAICS 325414), with secondary capabilities in testing laboratories (NAICS 541380) and life sciences research (NAICS 541715). This positions them as a mission-critical supplier in the federal blood and biologics supply chain, serving high-reliability healthcare environments that demand end-to-end chain-of-custody integrity and regulatory compliance. As a Wisconsin-based entity structured as an 8H concern, VERSITI WISCONSIN, INC. operates as a specialized provider with a focused geographic footprint centered on federal medical logistics. While they hold no formal government certifications beyond their entity structure, their consistent performance in high-stakes biological product delivery and transfusion medicine services establishes them as a trusted, operationally mature partner within the federal healthcare ecosystem.